● Recruiting

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Condition: Endometrial Cancer · Sponsor: Daiichi Sankyo

PhasePhase 3

Planned participants710

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study is designed to assess efficacy and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial cancer with various HER2 expression levels.

This description comes directly from the study's public registry record.

Talk to the study team

Contact for Trial Information · 908-992-6400 · CTRinfo_us@daiichisankyo.com

Always discuss trial participation with your own doctor first.

Locations (75)

Broward Health Medical Center	Fort Lauderdale, Florida, United States	Recruiting
Miami Cancer Institute	Miami, Florida, United States	Recruiting
Mount Sinai Medical Center	Miami Beach, Florida, United States	Recruiting
Parkview Research Center	Fort Wayne, Indiana, United States	Recruiting
Trials365 LLC	Shreveport, Louisiana, United States	Recruiting
FirstHealth of the Carolinas, Inc.	Pinehurst, North Carolina, United States	Recruiting
University of Cincinnati Physicians Group, LLC	Cincinnati, Ohio, United States	Recruiting
Avera Medical Group Gynecologic Oncology Sioux Falls	Sioux Falls, South Dakota, United States	Recruiting
Texas Oncology, P.A. - Tyler	Sioux Falls, South Dakota, United States	Recruiting
Texas Oncology San Antonio Medical Center	San Antonio, Texas, United States	Recruiting
Hospital Italiano de Buenos Aires	Ciudad Autonoma Buenos Aires, Argentina	Recruiting
Sanatorio Allende Cerro	Córdoba, Argentina	Recruiting

+ 63 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07022483